Market closedNon-fractional
QuidelOrtho Corporation/QDEL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Ticker
QDEL
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
San Diego, United States
Employees
7,100
Website
www.quidelortho.com
QDEL Metrics
BasicAdvanced
$2.6B
Market cap
-
P/E ratio
-$26.39
EPS
0.17
Beta
-
Dividend rate
Price and volume
Market cap
$2.6B
Beta
0.17
Financial strength
Current ratio
1.555
Quick ratio
0.712
Long term debt to equity
73.247
Total debt to equity
78.118
Interest coverage (TTM)
0.87%
Management effectiveness
Return on assets (TTM)
1.32%
Return on equity (TTM)
-42.51%
Valuation
Price to revenue (TTM)
0.893
Price to book
0.77
Price to tangible book (TTM)
-8.13
Price to free cash flow (TTM)
-21.544
Growth
Revenue change (TTM)
-7.95%
Earnings per share change (TTM)
-1,519.71%
3-year revenue growth (CAGR)
15.41%
3-year earnings per share growth (CAGR)
6.68%
What the Analysts think about QDEL
Analyst Ratings
Majority rating from 7 analysts.
QDEL Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$711M
-4.26%
Net income
-$1.7B
-24,471.43%
Profit margin
-239.94%
-25,625.53%
QDEL Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.26
$0.90
$1.17
$0.44
-
Expected
$0.28
$0.60
$2.05
$0.39
-$0.22
Surprise
-6.98%
50.75%
-42.87%
12.61%
-
QDEL News
AllArticlesVideos
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewsWire·1 month ago
The Schall Law Firm Encourages Investors Who Have Suffered Losses In QuidelOrtho Corporation To Make Contact
Accesswire·1 month ago
DEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for QuidelOrtho Corporation stock?
QuidelOrtho Corporation (QDEL) has a market cap of $2.6B as of July 27, 2024.
What is the P/E ratio for QuidelOrtho Corporation stock?
The price to earnings (P/E) ratio for QuidelOrtho Corporation (QDEL) stock is 0 as of July 27, 2024.
Does QuidelOrtho Corporation stock pay dividends?
No, QuidelOrtho Corporation (QDEL) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next QuidelOrtho Corporation dividend payment date?
QuidelOrtho Corporation (QDEL) stock does not pay dividends to its shareholders.
What is the beta indicator for QuidelOrtho Corporation?
QuidelOrtho Corporation (QDEL) has a beta rating of 0.17. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell QuidelOrtho Corporation stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.